학술논문

Long-Term Treatment With First-Line Ocrelizumab in Patients With Early RMS: 9-Year OPERA Subgroup Analysis
Document Type
Journal
Source
NEUROLOGY; APR 25 2023, 100 17, p1920 8p. Supplement: 2
Subject
Language
English
ISSN
1526632X